Systemic Transforming Growth Factor-??1 Gene Therapy Induces Foxp3+ Regulatory Cells, Restores Self-Tolerance, and Facilitates Regeneration Of Beta Cell Function in Overtly Diabetic Nonobese Diabetic Mice
- 1 May 2005
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 79 (9) , 1091-1096
- https://doi.org/10.1097/01.tp.0000161223.54452.a2
Abstract
Background. Type 1 diabetes results from auto-aggressive T–cell-mediated destruction of beta cells of the pancreas. Recent data suggest that restoration of self-tolerance may facilitate islet-cell regeneration/recovery. In view of the immunoregulatory activity of transforming growth factor (TGF)-β1, we investigated whether systemic TGF-β1 gene therapy blocks islet destructive autoimmunity and facilitates regeneration of beta-cell function in overtly diabetic nonobese diabetic (NOD) mice. Methods. We used site-directed mutagenesis to create cysteine to serine mutation at sites 224 and 226 and constructed a replication deficient adenovirus (Ad) vector encoding active form of human TGF-β1 (Ad-hTGF-β1). Overtly diabetic NOD mice received intravenous injection of Ad-hTGF-β1. Seven to 14 days after the injection, the mice received transplants with 500 syngeneic islets under the kidney capsule. Islet-graft survival and regeneration of endogenous beta-cell function were examined. Results. Syngeneic islet grafts failed by day 17 in all untreated mice, whereas Ad-hTGF-β1 therapy prolonged survival of islet grafts. Islet grafts from treated mice showed well-preserved islets with a peri-islet infiltrate primarily of CD4+ T cells and expression of CD25 and Foxp3. Systemic TGF-β1 gene therapy was associated with islet regeneration in the native pancreas. Native pancreas of treated mice revealed islets staining strongly for insulin. Similar to what was found in the syngeneic islet graft, there were well-demarcated peri-islet infiltrates that were positive for CD4, TGF-β1, and Foxp3. Conclusions. Our data demonstrate that systemic TGF-β1 gene therapy blocks islet destructive autoimmunity, facilitates islet regeneration, and cures diabetes in diabetic NOD mice.Keywords
This publication has 27 references indexed in Scilit:
- CD25+ CD4+ T Cells, Expanded with Dendritic Cells Presenting a Single Autoantigenic Peptide, Suppress Autoimmune DiabetesThe Journal of Experimental Medicine, 2004
- In Vitro–expanded Antigen-specific Regulatory T Cells Suppress Autoimmune DiabetesThe Journal of Experimental Medicine, 2004
- Adult pancreatic β-cells are formed by self-duplication rather than stem-cell differentiationNature, 2004
- Mechanisms of tolerance induced by TGFβ-treated APC: CD4 regulatory T cells prevent the induction of the immune response possibly through a mechanism involving TGFβEuropean Journal of Immunology, 2004
- Conversion of Peripheral CD4+CD25− Naive T Cells to CD4+CD25+ Regulatory T Cells by TGF-β Induction of Transcription Factor Foxp3 The Journal of Experimental Medicine, 2003
- Prolongation of skin graft survival by modulation of the alloimmune response with alternatively activated dendritic cells1Transplantation, 2003
- Recovery of the Endogenous β Cell Function in the NOD Model of Autoimmune DiabetesThe International Journal of Cell Cloning, 2003
- Expression of Transgene Encoded TGF-β in Islets Prevents Autoimmune Diabetes in NOD Mice by a Local MechanismJournal of Autoimmunity, 2002
- Assessment of Adenoviral Vector Safety and Toxicity: Report of the National Institutes of Health Recombinant DNA Advisory CommitteeHuman Gene Therapy, 2002
- The Inhibitory Effects of Transforming Growth Factor-Beta-1 (TGF-β1) in Autoimmune DiseasesJournal of Autoimmunity, 2000